This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, A. M. Search for Related Content PubMed PubMed Citation Articles by Murphy, A. M. Related Collections Related Article

(Circulation Research. 2004;95:1043.)
© 2004 American Heart Association, Inc.

Editorial

Another New Kinase Targets Troponin I

Anne M. Murphy

From the Division of Cardiology, Department of Pediatrics and Institute of Molecular Cardiobiology, Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Johns Hopkins University School of Medicine, Ross 1144, 720 Rutland Ave, Baltimore, MD 21205. E-mail murphy@jhmi.edu

See related article, pages 1091–1099

Key Words: troponin • protein phosphorylation

An extract of the first 250 words of the full text is provided, because this article has no abstract.

In this issue of Circulation Research, Haworth et al¹ report that protein kinase D (PKD), a serine kinase, phosphorylates the cardiac thin filament protein, troponin I (TnI). These investigators performed a detailed and complete set of experiments, initially noting the association of TnI and PKD, and then mapping the sites that PKD phosphorylates, Ser22 and Ser23. PKD treatment of myocytes was further demonstrated to result in desensitization of the myofilaments to calcium and accelerated isometric crossbridge cycling.¹

Why is finding an additional kinase for TnI important? TnI is a critical component of the calcium switch of striated muscle, and the cardiac specific isoform is further specialized because of the presence of an amino-terminal region containing protein kinase A (PKA) sites. Troponin (Tn) consists of three subunits including TnI, the inhibitory component, which inhibits actin-myosin interactions at diastolic calcium levels, TnC, the calcium binding subunit, and TnT, which anchors Tn to tropomyosin (Tm) but also contributes to regulation of muscle activation. During systole, a regulatory Ca²⁺ -binding site on TnC is occupied, increasing the affinity of TnC for TnI and lessening the interaction between TnI and actin-Tm. This results in movement of Tm-Tn on the thin filament, releasing the inhibition of actin-myosin interactions and increasing the probability of cycling of the crossbridge and muscle shortening (reviewed by Tobacman²).

Studies conducted in the 1970s demonstrated TnI to be a target of PKA phosphorylation, and Solaro et al³ demonstrated the phosphorylation of TnI on administration of adrenaline to perfused hearts. Since . . . [Full Text of this Article]

Related Article:

Protein Kinase D Is a Novel Mediator of Cardiac Troponin I Phosphorylation and Regulates Myofilament Function

Robert S. Haworth, Friederike Cuello, Todd J. Herron, Gereon Franzen, Jonathan C. Kentish, Mathias Gautel, and Metin Avkiran
Circ. Res. 2004 95: 1091-1099. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325. [Abstract] [Full Text] [PDF]